Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central nervous system lymphoma: Results of CALGB 51101 [Alliance]
- Citation:
- J Clin Oncol vol 39 (no. 15_suppl) 7506
- Meeting Instance:
- ASCO 2021
- Year:
- 2021
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3851
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171
- Corr. Author:
- Authors:
- Tracy T. Batchelor Sharmila Giri Amy S. Ruppert Nancy L. Bartlett Eric Hsi Bruce D. Cheson Lakshmi Nayak John P. Leonard James L. Rubenstein
- Networks:
- CA824, CAPITAL, LAPS-MA036, LAPS-MN026, LAPS-MO011, NY018
- Study
- CALGB-51101
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: